Paradoxical Dampening of Anti-Islet Self-Reactivity but Promotion of Diabetes by OX40 Ligand

Journal of Immunology

Volumn 171, Issue 12, 2003, Pages 6954-6960

  Martin Orozco, Natalia ^a,c   Chen, Zhibin ^a   Poirot, Laurent ^a   Hyatt, Elzbieta ^a   Chen, Andy ^a   Kanagawa, Osami ^b   Sharpe, Arlene ^a   Mathis, Diane ^a,d   Benoist, Christophe ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD134 ANTIGEN; CD27 ANTIGEN; INTERLEUKIN 2 RECEPTOR; LIGAND; MEMBRANE PROTEIN; OX40 LIGAND; PEPTIDE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLELE; ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BIOSYNTHESIS; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOLOGY; DIABETES MELLITUS; DISEASE COURSE; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOPHENOTYPING; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; METABOLISM; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NONHUMAN; NUTRITIONAL DEFICIENCY; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE;

EID: 0347627710     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.12.6954     Document Type: Article

References (41)

1. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell 85:291.
2. Luhder, F., P. Höglund, J. P. Allison, C. Benoist, and D. Mathis. 1998. Cytotoxic T lymphocyte-associated antigen 4 regulates the unfolding of autoimmune diabetes. J. Exp. Med. 187:427.
3. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431.
4. Balasa, B., T. Krahl, G. Patstone, J. Lee, R. Tisch, H. O. McDevitt, and N. Sarvetnick. 1997. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J. Immunol. 159:4620.
5. + T cells dissociated from activation of antigen-presenting cells. Immunity 16:719.
6. Calderhead, D. M., J. E. Buhlmann, A. J. van den Eertwegh, E. Claassen, R. J. Noelle, and H. P. Fell. 1993. Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions. J. Immunol. 151:5261.
7. + T cells with homology to tumor necrosis factor. J. Exp. Med. 180:757.
8. Baum, P. R., R. B. Gayle III, F. Ramsdell, S. Srinivasan, R. A. Sorensen, M. L. Watson, M. F. Seldin, E. Baker, G. R. Sutherland. K. N. Clifford, and et al. 1994. Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-I-regulated protein gp34. EMBO J. 13:3992.
9. Ohshima, Y., Y. Tanaka, H. Tozawa, Y. Takahashi, C. Maliszewski, and G. Delespesse. 1997. Expression and function of OX40 ligand on human dendritic cells. J. Immunol. 159.3838.
10. Weinberg, A. D., K. W. Wegmann, C. Funatake, and R. H. Whitham, 1999. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. J. Immunol. 162:1818.
11. Imura, A., T. Hori, K. Imada, T. Ishikawa, Y. Tanaka, M. Maeda, S. Imamura, and T. Uchiyama. 1996. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J. Exp. Med. 183-2185.
12. Gramaglia, I., A. D. Weinberg. M. Lemon. and M. Croft. 1998. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J. Immunol. 161:6510.
13. Rogers, P. R., J. Song, I. Gramaglia, N. Killeen, and M. Croft. 2001. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells, lmmunity. 15:445.
14. De Smedt, T., J. Smith. P. Baum, W. Fanslow, E. Butz, and C. Maliszewski. 2002. Ox40 costimulation costimulation enhances the development ofT cell responses induced by dendritic cells in vivo. J. lmmunol. 168:661.
15. Weinberg, A. D., M. M. Rivera, R. Prell, A. Morris, T. Ramstad, J. T. Vetto. W. J. Urba, G. Alvord, C. Bunce, and J. Shields. 2000. Engagement of the OX-40 receptor in vivo enhances antitumor immunity. J. Immunol. 164:2160.
16. Kopf, M., C. Ruedl, N. Schmitz, A. Gallimore, K. Lefrang, B. Ecabert, B. Odermatt, and M. F. Bachmann. 1999, OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. lmmunity 11:699.
17. Pippig, S. D., C. Pena-Rossi, J. Long, W. R. Godfrey, D. J. Fowell, S. L. Reiner. M. L. Birkeland, R. M. Locksley, A. N. Barclay, and N. Killeen. 1999. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40). J. Immunol. 163:6520.
18. Gramaglia, I., A. Jember, S. D. Pippig, A. D. Weinberg, N. Killeen, and M. Croft. 2000. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J. Immunol. 165:3043.
19. Chen, A. I., A. J. McAdam, J. E. Buhlmann, S. Scott, M. L. Lupher, Jr., E. A. Greenfield, P. R. Baum, W. C. Fanslow, D. M. Calderhead, G. J. Freeman, and A. H. Sharpe. 1999. Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. Immunity 11:689.
20. Murata, K., N. Ishij, H. Takano, S. Miura, L. C. Ndhlovu, M. Nose, T. Noda, and K, Sugamura. 2000. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J. Exp. Med. 191:365.
21. Ndhlovu, L. C., N. Ishii, K. Murata, T. Sato, and K. Sugamura. 2001. Critical involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis. J. Immunol. 167:2991.
22. Matsumura, Y., T. Hori, S. Kawamata, A. Imura, and T. Uchiyama. 1999. lntracellular signaling of gp34, the OX40 ligand: induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40. J. Immunol. 163:3007.
23. Yoshioka, T., A. Nakajima, H. Akiba, T. Ishiwata, G. Asano, S. Yoshino, H. Yagita, and K. Okumura. 2000. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis. Eur. J. Immunol. 30:2815
24. Nohara, C., H. Akiba, A. Nakajima, A. Inoue, C. S. Koh, H. Ohshima, H. Yagita, Y. Mizuno, and K. Okumura. 2001. Amelioration of experimental autoimmune encephalomyelitis with anti-OX40 ligand monoclonal antibody: a critical role for OX40 ligand in migration, but not development, of pathogenic T cells. J. Immunol. 166:2108.
25. Katz, J. D., B. Wang, K. Haskins, C. Benoist, and D. Mathis. 1993. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74:1089.
26. Gonzalez, A., J. D. Katz, M. G. Mattei, H. Kikutani, C. Benoist, and D. Mathis. 1997. Genetic control of diabetes progression. Immunity 7:873.
27. Kanagawa, O., A. Militech, and B. A. Vaupel. 2002. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice. J. Immunol. 168:6159.
28. Judkowski, V., C. Pinilla, K. Schroder, L. Tucker, N. Sarvetnick, and D. B. Wilson. 2001. Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J. Immunol. 166:908.
29. + T cells in autoimmune diabetes. Nat. Immun. 2:1117
30. Ghosh, P., S. M. Palmer, N. R. Rodrigues, H. J. Cordell, C. M. Hearne, R. J. Cornall, J.-B. Prins, P. McShane, G. M. Lathrop, and L. B. Peterson. 1993. Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat. Genet. 4:404
31. Brodnicki, T. C., F. Quirk, and G. Morahan. 2003. A susceptibility allele from a non-diabetes-prone mouse strain accelerates diabetes in NOD congenic mice. Diabetes 52:218.
32. Bansal-Pakala, P., A. G. Jember, and M. Croft. 2001. Signaling through OX40 (CD134) breaks peripheral T-cell tolerance. Nat. Med. 7:907.
33. Hoglund, P., J. Mintern, C. Waltzinger, W. Heath, C. Benoist, and D. Mathis. 1999. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J. Exp. Med. 189:331.
34. + T cells expressing identical endogenous TCR-α chains. J. Immunol. 157:4726.
35. Morgan, D. J., C. Kurts, H. T. C. Kreuwel, K. L. Holst. W. R. Heath, and L. A. Sherman. 1999. Ontogeny of T cell tolerance to peripherally expressed antigens. Proc. Natl. Acad. Sci. USA 96:3854
36. Mintern, J. D., R. M. Sutherland, A. M. Lew, K. Shortman, F. R. Carbone, and W. R. Heath. 2002. Constitutive, but not inflammatory, cross-presentation is disabled in the pancreas of young mice. Eur. J. Immunol. 32:1044.
37. Malmstrom, V., D. Shipton, B. Singh, A. Al Shamkhani, A. Al Shamkhani, M. J. Puklavec, A. N. Barclay, and F. Powrie. 2001. CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. J. Immunol. 166:6972.
38. Ting, J. P. and J. Trowsdale. 2002. Genetic control of MHC class II expression. Cell 109(Suppl):S21.
39. Luhder, F., C. Chambers, J. P. Allison, C. Benoist, and D. Mathis. 2000. Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells. Proc. Natl. Acad. Sci. USA 97:12204.
40. Katz, J. D., C. Benoist, and D. Mathis. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268:1185.
41. + T cells into high IL-4-producing effectors. Blood 92:3338.